MyFinsight
Home
Compare
About
Recent SEC Filings
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
10/2
NIKE, Inc.
(NKE)
10/2
DARDEN RESTAURANTS INC
(DRI)
9/30
CONAGRA BRANDS INC.
(CAG)
9/29
Carnival Corp Ltd.
(CCL)
9/29
URANIUM ENERGY CORP
(UEC)
9/29
COPART INC
(CPRT)
9/24
BLACKBERRY Ltd
(BB)
9/24
PAYCHEX INC
(PAYX)
9/23
GENERAL MILLS INC
(GIS)
9/22
ADOBE INC.
(ADBE)
9/18
KROGER CO
(KR)
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Net Income
-$4,866,635
EPS
-$0.2
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Research and development
2,066,825
2,565,244
2,878,529.5*
2,177,922
General and administrative
2,839,763
3,140,712
2,454,900*
3,294,456
Total operating expenses
4,906,588
5,705,956
5,333,429.5
5,472,378
Loss from operations
-4,906,588
-5,705,956
-5,333,429.5*
-5,472,378
Change in estimated fair value of warrant liability
-
-
0*
0
Gain on settlement of warrants
-
-
0*
0
Loss on issuance of related party convertible notes payable at fair value
-
-
0*
0
Change in estimated fair value of related party convertible notes payable
-
-
0*
0
Interest expense
5,063
5,062
5,062.5*
5,063
Interest income
45,016
85,269
145,952.5*
69,971
Total other income, net
39,953
80,207
140,890*
64,908
Net loss
-4,866,635
-5,625,749
-5,192,539.5
-5,407,470
Basic EPS
-0.2
-0.24
-0.236
-0.25
Diluted EPS
-0.2
-0.24
-0.236
-0.25
Basic Average Shares
23,871,850
23,537,134
22,024,011
21,394,965
Diluted Average Shares
23,871,850
23,537,134
22,024,011
21,394,965
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
ACTU Income Statement Sankey Diagram
Sankey diagram visualizing ACTU income statement for the period
Interest income
$45,016
(83.48%↑ Y/Y)
Net loss
-$4,866,635
(18.20%↑ Y/Y)
Total other income,
net
$39,953
(105.18%↑ Y/Y)
Interest expense
$5,063
(0.02%↑ Y/Y)
Loss from operations
-$4,906,588
(17.80%↑ Y/Y)
Total operating
expenses
$4,906,588
(-17.80%↓ Y/Y)
General and
administrative
$2,839,763
(-11.37%↓ Y/Y)
Research and development
$2,066,825
(-25.25%↓ Y/Y)
Buy us a coffee
ACTUATE THERAPEUTICS, INC. (ACTU)
ACTUATE THERAPEUTICS, INC. (ACTU)